财中社12月2日电新华制药(000756/00719)发布关于获得《药品补充申请批准通知书》等相关情况的公告。近日,公司收到国家药品监督管理局核准签发的乳果糖口服溶液(100ml:66.7g)《药品补充申请批准通知书》,批准了该产品的上市许可持有人变更申请。此次申请符合药品注册的有关要求,批准后,公司将成为该产品的上市许可持有人。乳果糖口服液主要用于慢性或习惯性便秘及肝性脑病的治疗。根据数据显示,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.